Side by Side
Compare
Read two to four stocks on the same scale — return, valuation and volatility in one table.
Selected5Y Return
Partial Period · Jun 24, 2024 — Aug 31, 2026
Four symbols is the limit; remove one to add another.
Period Return
Each series is converted to a percentage of its own starting point, so all of them begin at zero. What is compared is the return over the period, not price levels.
| Metric | ALMS | JAGX | GTBP | ANVS |
|---|---|---|---|---|
| Return | ||||
| Last Price | 11.10 | 0.66 | 0.24 | 1.39 |
| Daily Change | − 2.29% | − 4.97% | − 4.52% | + 0.36% |
| Period ReturnPast 5 Years | − 14.96%Jun 24, 2024 — Aug 31, 2026 | − 100.00% | − 99.90% | — |
| Valuation | ||||
| Market Cap | $1.42 B | $3.24 M | $10.7 M | $48.0 M |
| P/E Ratio | — | — | 1.99 | — |
| Dividend Yield | — | — | — | — |
| Net MarginTrailing 12M | 6,114.6% | 130.9% | 26,209.5% | — |
| Risk | ||||
| Beta | 0.68 | -0.24 | 0.85 | — |
| 52-Week Range | 3.76 — $31.35 | 0.69 — $85.40 | 0.25 — $1.37 | — |
| Company | ||||
| Sector | — | — | — | — |
| Industry | Pharmaceuticals | Pharmaceuticals | Biotechnology | Biotechnology |
Company
- ALMSPharmaceuticals
- JAGXPharmaceuticals
- GTBPBiotechnology
- ANVSBiotechnology
Metrics could not be loaded for ANVS: P/E, dividend, beta and the 52-week range stay empty in that column.
CacheUpdated 23:19May Be Out Of Date
To Understand This